37
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Evaluation of the antimicrobial effects in vivo of Triaz® Gel (benzoyl peroxide special gel), Cleocin-T® Lotion (clindamycin phosphate lotion), and Azelex® Cream (azelaic acid cream) in humans

&
Pages S7-S10 | Published online: 12 Jul 2009
 

Abstract

This single-blind, 4-week study compared the in vivo antimicrobial efficacy of three topical antimicrobial products used to treat acne: Triaz® 10% Gel (benzoyl peroxide special gel), Azelex® Cream (azelaic acid cream), and 2% Cleocin-T® Lotion (clindamycin phosphate lotion). There were three parallel groups, each containing males and females with minimum baseline Propionibacterium acnes of 10 000 colony forming units per cm2. Each product was applied twice daily for 4 weeks and P. acnes was sampled using the scrub procedures of Williamson and Kligman on the forehead and both cheeks, at baseline and at 2 and 4 weeks. The results showed that Triaz Gel produced substantial and significantly superior reductions in P. acnes, compared with those produced by Cleocin-T Lotion and Azelex Cream as early as 2 weeks and continuing through 4 weeks of treatment (P=<0.01). Further, while Triaz Gel and Cleocin-T Lotion produced significant reductions in P. acnes compared with baseline after 2 and 4 weeks, Azelex Cream appeared to produce no reduction in P. acnes at either time point.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.